RUNX1 and myeloid sarcoma: The study by Haridy et al. investigated the role of the RUNXOR/RUNX1 axis in MS development and progression, measuring serum expression levels of RUNXOR, RUNX1, and other critical mRNAs and proteins in MS patients compared to healthy controls.